Cumberland Pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland is dedicated to providing high quality products which address unmet medical needs.
View Top Employees from Cumberland PharmaceuticalsWebsite | https://www.cumberlandpharma.com |
Ticker | CPIX |
Revenue | $47 million |
Funding | $87 million |
Employees | 72 (72 on RocketReach) |
Founded | 1999 |
Address | 2525 W End Ave, Ste 950, Nashville, Tennessee 37203, US |
Phone | (615) 255-0068 |
Fax | (615) 255-0094 |
Technologies |
JavaScript,
HTML,
reCAPTCHA
+15 more
(view full list)
|
Industry | Pharmaceuticals, Drug Manufacturing & Research, Biotechnology, Drug Delivery, Science and Engineering, Healthcare, Health Care, Medical Testing & Clinical Laboratories |
Web Rank | 6 Million |
Keywords | Cumberland Pharmaceuticals, Nashville Biotech Companies, Cumberland Pharmaceuticals Inc, Cumberland Investors, Cumberland |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 621 Companies, NAICS Code 32 Companies, NAICS Code 62151 Companies, NAICS Code 62 Companies, NAICS Code 325 Companies, NAICS Code 6215 Companies |
Looking for a particular Cumberland Pharmaceuticals employee's phone or email?
The Cumberland Pharmaceuticals annual revenue was $47 million in 2023.
Marty Cearnal is the Executive Vice President, Chief Commercial Officer of Cumberland Pharmaceuticals.
72 people are employed at Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals is based in Nashville, Tennessee.
The NAICS codes for Cumberland Pharmaceuticals are [3254, 621, 32, 62151, 62, 325, 6215].
The SIC codes for Cumberland Pharmaceuticals are [283, 28].